Authors:
Porst, H
Rosen, R
Padma-Nathan, H
Goldstein, I
Giuliano, F
Ulbrich, E
Bandel, T
Citation: H. Porst et al., The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial, INT J IMPOT, 13(4), 2001, pp. 192-199
Citation: H. Porst, Diabetic impotence treated by intracavernosal injections: High treatment compliance and increasing dosage of vaso-active drugs - Editorial comment, EUR UROL, 40(4), 2001, pp. 403-403
Citation: H. Porst, Vardenafil increases penile rigidity and tumescence in men with erectile dysfunction after a single oral dose - Editorial comment, EUR UROL, 40(2), 2001, pp. 189-189
Authors:
Muller, MJ
Ruof, J
Graf-Morgenstern, M
Porst, H
Benkert, O
Citation: Mj. Muller et al., Quality of partnership in patients with erectile dysfunction after sildenafil treatment, PHARMACOPS, 34(3), 2001, pp. 91-95
Authors:
Eid, JF
Nehra, A
Andersson, KE
Heaton, J
Lewis, RW
Morales, A
Moreland, RB
Mulcahy, JJ
Porst, H
Pryer, JL
Sharlip, ID
Wagner, G
Wyllie, M
Citation: Jf. Eid et al., First International Conference on the Management of Erectile Dysfunction -Overview consensus statement, INT J IMPOT, 12, 2000, pp. S2-S5
Authors:
Wiese, M
Berr, F
Lafrenz, M
Porst, H
Oesen, U
Citation: M. Wiese et al., Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in Germany: A 20-year multicenter study, HEPATOLOGY, 32(1), 2000, pp. 91-96
Authors:
Behrends, S
Steenpass, A
Porst, H
Scholz, H
Citation: S. Behrends et al., Expression of nitric oxide-sensitive guanylyl cyclase subunits in human corpus cavernosum, BIOCH PHARM, 59(6), 2000, pp. 713-717
Citation: M. Fabra et H. Porst, Bulbocavernosus-reflex latencies and pudendal nerve SSEP compared to penile vascular testing in 669 patients with erectile failure and other sexual dysfunction, INT J IMPOT, 11(3), 1999, pp. 167-175
Authors:
Meuleman, E
Feng, YP
Giuliano, F
Glina, S
Sohn, MHH
Porst, H
Sarramon, JP
Vermeulen, A
Pryor, JP
Citation: E. Meuleman et al., The process of care model for evaluation and treatment of erectile dysfunction - Comments, INT J IMPOT, 11(2), 1999, pp. 70-74
Citation: H. Porst, Maximisation of the erectile response in the investigation of impotence - by RD Mills and KK Sethia, INT J IMPOT, 11(1), 1999, pp. 33-34
Citation: H. Porst, Treatment off intracorporeal injection nonresponse with sildenafil alone or in combination with triple agent intracorporeal injection therapy - Editorial comment, J UROL, 162(6), 1999, pp. 1997-1998
Authors:
Porst, H
Buvat, J
Meuleman, E
Michal, V
Wagner, G
Citation: H. Porst et al., Intracavernous Alprostadil Alfadex - an effective and well tolerated treatment for erectile dysfunction. Results of a long-term European study, INT J IMPOT, 10(4), 1998, pp. 225-231
Authors:
Williams, G
Abbou, CC
Amar, ET
Desvaux, P
Flam, TA
Nijeholt, GABLA
Lynch, SF
Morgan, RJ
Muller, SC
Porst, H
Pryor, JP
Ryan, P
Witzsch, UKF
Hall, MM
Place, VA
Spivack, AP
Todd, LK
Gesundheit, N
Citation: G. Williams et al., The effect of transurethral alprostadil on the quality of life of men witherectile dysfunction, and their partners, BR J UROL, 82(6), 1998, pp. 847-854